Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

URGNURGN
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in UROGEN PHARMA LTD

Yes. Goldman Sachs holds 819,834 shares of URGN (Urogen Pharma), worth $30.2M, as of its Q2 2026 13F filing. It increased the position by 221,306 shares (+37.0%) from Q1 2026. Goldman Sachs has held URGN in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$30.2M

Current Shares

819,834

Total Value Change

+$29.9M

Total Shares Change

+781,599

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
819,834
+37.0%
$30.2M0.0%$36.80
38
2026-Q1
Increased
598,528
+30.2%
$10.8M0.0%$17.98
35
2025-Q4
Increased
459,722
+8.2%
$10.8M0.0%$23.42
30
2025-Q3
Increased
424,916
+46.2%
$8.5M0.0%$19.95
37
2025-Q2
Increased
290,577
+2.2%
$4M0.0%$13.70
27
2025-Q1
Decreased
284,334
-10.4%
$3.1M0.0%$11.06
0
2024-Q4
Increased
317,522
+0.5%
$3.4M0.0%$10.65
27
2024-Q3
Increased
315,957
+19.9%
$4M0.0%$12.70
32
2024-Q2
Increased
263,606
+131.5%
$4.4M0.0%$16.78
43
2024-Q1
Decreased
113,862
-0.3%
$1.7M0.0%$15.00
0
2023-Q4
Increased
114,221
+112.9%
$1.7M0.0%$15.00
41
2023-Q3
Increased
53,647
+70.9%
$751,5940.0%$14.01
37
2023-Q2
Decreased
31,383
-55.5%
$324,8140.0%$10.35
0
2023-Q1
Increased
70,555
+200.6%
$651,9280.0%$9.24
39
2022-Q4
Decreased
23,475
-0.5%
$208,2230.0%$8.87
0
2022-Q3
Decreased
23,592
-38.3%
$196,0000.0%$8.32
0
2022-Q2
First report
38,235
-
$313,0000.0%$8.19
0

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used